GCH1 and coronary artery disorder: Under normal conditions, HSP70, in partnership with CHIP (an E3 ubiquitin ligase), targets specific proteins for degradation, which may contribute to lower GCH1 protein levels and thus reduce NO production in CHD-PAH [30].